Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01156116 · ClinicalTrials.gov registry record · NA
Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT01156116 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 39 participants.
The verdict
NCT01156116, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
Although obstructive sleep apnea (OSA) is associated with impaired glucose tolerance and diabetes, it remains unclear whether OSA treatment with continuous positive airway pressure (CPAP) has metabolic benefits. The objective of this study is to determine the effect of 8-hour nightly CPAP treatment on glucose metabolism in individuals with prediabetes and OSA.
Interventions
- DRUG Placebo
- DEVICE CPAP mask
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2009-10 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01156116
The ClinicalTrials.gov registry entry for NCT01156116 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01156116 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01156116 about?
NCT01156116 is a clinical study titled "Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk". Although obstructive sleep apnea (OSA) is associated with impaired glucose tolerance and diabetes, it remains unclear whether OSA treatment with continuous positive airway pressure (CPAP) has metabolic benefits. The objective of this study is to determine the effect of 8-hour nightly CPAP treatment ...
What is the current status of trial NCT01156116?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2009-10. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01156116?
The interventions under investigation include: Placebo (DRUG), CPAP mask (DEVICE).
Who is sponsoring clinical trial NCT01156116?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.